Our Scientific Mission

The mission of the HIV Vaccine Trials Network (HVTN) is to enhance the discovery, and drive the development, of a safe and globally effective vaccine for the prevention of HIV through well-designed clinical research trials which objectively and ethically address the critical questions of the field. This is done using an objective clinical trial platform to evaluate safety, immunogenicity and efficacy of candidate vaccines, as well as designing clinical trials that will provide insight on ways to enhance the effectiveness of subsequent vaccines. Candidates include T-cell-mediated vaccines, vaccines that elicit neutralizing antibodies (nAb) as well as those that elicit mucosal immune responses, and novel adjuvants to improve the breadth, quality, and magnitude of the immune response to HIV-1 immunogens.

› Download the HVTN Scientific Agenda